Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10
Denise Fischer(Novartis (Switzerland)), Dalia Cohen(Regulus Therapeutics (United States)), Roland Widmer(Novartis (Switzerland)), Nancy Trogani, Richard Cai, Umesh Bhatia(New York Medical College), Robert D. Terry(Georgia Southern University), Chuanzheng Song, Fred A.M. Asselbergs(Novartis (Switzerland)), Peter Atadja(University of Health and Allied Sciences)
Cited by 137
Related Papers
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Distribution of cholinergic neurons in rat brain: Demonstrated by the immunocytochemical localization of choline acetyltransferase
|The Journal of Comparative Neurology|1983|967
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
|Journal of Clinical Oncology|2009|410
Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects
|Journal of Biological Chemistry|1999|393
Design of a genome-wide siRNA library using an artificial neural network
|Nature Biotechnology|2005|386